Small Molecules & Immunotherapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
88
NCT05696483
Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 20, 2023
Completion: Feb 1, 2026
Loading map...